Friday 6 November 2026
Export MTD’s income statement to Excel — free account
Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
- Revenue
- +6.27%
- EPS
- +16.2%
- Free cash flow
- +33.0%
- Total debt
- −8.42%
Quarter to September 2026, against a year earlier
1,740.98
61.90
+3.69%
Follow MTD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 8 | 9 |
| (1,154.87%) | (781.77%) | (736.36%) | (1,089.06%) | ||
| 25.00% | 25.35% | 25.61% | 25.89% | ||
ROIC |
33.91% | 33.09% | 35.40% | 0.00% | |
Return on Tangible Assets |
86.04% | 83.03% | 92.52% | 97.58% | |
Average Days of Receivables |
70.55 | 63.21 | 64.59 | 63.74 | |
Free Cash Flow per Share |
41.18 | 39.13 | 42.94 | 49.31 | |
Free Cash Flow |
848.65 | 793.83 | 863.97 | 984.37 | |
Capital Expenditures |
(107.12) | (107.28) | (111.20) | — | |
| Other line items | |||||
Cash ROIC |
38.66% | 35.32% | 39.70% | 45.71% | |
Accounts Receivable Turnover |
5.50 | 6.07 | 5.85 | 5.91 | |
Accounts Payable Turnover |
6.78 | 7.76 | 7.37 | 6.54 | |
Inventory Turnover |
4.48 | 4.37 | 4.11 | 3.95 | |
Average Days of Payables |
59.50 | 50.01 | 51.05 | 57.32 | |
Days of Inventory on Hand |
86.41 | 88.52 | 91.43 | 96.51 | |
Tax Rate |
(0.17) | (0.17) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
4.95% | 5.00% | 5.03% | 5.01% | |
Selling, General and Administrative Expense of Revenue |
24.79% | 24.79% | 24.91% | 24.98% | |
Share Based Compensation of Revenue |
0.56% | 0.56% | 0.55% | 0.55% | |
Interest Coverage |
16.32 | 16.34 | 16.94 | 0.00 | |
Operating CF/Net income |
1.10 | 1.03 | 1.08 | 1.05 | |
Depreciation/Fixed assets |
0.15 | 0.16 | 0.16 | 0.16 | |
Capex/Depreciation |
(0.85) | (0.83) | (0.85) | 0.00 | |
Revenue per Share |
195.36 | 201.61 | 205.44 | 210.30 | |
Operating CF per Share |
46.37 | 44.42 | 48.46 | 49.31 | |
Capex per Share |
(5.20) | (5.29) | (5.53) | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026